A process for preparing 4-pentafluorosulfanylbenzoylguanidines of formula I ##STR00001## wherein R1 to R4 have the meanings indicated in the specification. The compounds of formula I are NHE1 inhibitors and can be employed, for example, for the treatment of cardiovascular disorders.